D.Western Therapeutics Institute, Inc.
4576株式会社デ・ウエスタン・セラピテクス研究所
Latest half-year results
First half · fiscal year to 2026-12 · filed 2026-08-13For the first half of the fiscal year to 2026-12: Revenue ¥0 billion (-80.9% YoY), Ordinary income ¥-0.3 billion, Net income ¥-0.3 billion.
| This period | Year on year | |
|---|---|---|
| Revenue | ¥33m | -80.9% |
| Ordinary profit | −¥322m | — |
| Net profit to owners | −¥323m | — |
From the securities report on EDINET, which states no forecast. History via /v1/companies/4576/earnings-releases.
Financials
Japan GAAP · consolidated · fiscal year to 2025-12-31- Revenue
- ¥388m
- Net income
- −¥632m
- ROE
- —
- Equity ratio
- 66.1%
- Dividend / share
- —
- Employees
- 19
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | ¥388m | −¥632m | ¥2,169m | ¥1,435m | — | ¥-13.19 | −¥494m |
| 2024-12-31 | ¥472m | −¥1,290m | ¥1,669m | ¥734m | — | ¥-36.74 | −¥1,299m |
| 2023-12-31 | ¥428m | −¥812m | ¥2,373m | ¥1,280m | — | ¥-25.56 | −¥587m |
| 2022-12-31 | ¥448m | −¥430m | ¥2,956m | ¥1,873m | — | ¥-14.5 | −¥355m |
| 2021-12-31 | ¥414m | −¥149m | ¥2,463m | ¥2,035m | — | ¥-5.08 | −¥176m |
Indicators
Computed by us from filings · fiscal year to 2025-12-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | — | — |
| Ordinary margin | -1.6266 | 1 |
| Equity ratio, % | 66.1 | 67.7 |
| Revenue growth | -0.178 | 3.1 |
| Net income growth | 0.5101 | 75.5 |
| Operating cash flow / assets | -0.2276 | 2.3 |
Results wording balance: +0.33. Proprietary text method; it describes the wording only and does not interpret context.
Interest example: if all ¥605m of reported debt repriced by 50 basis points, a year's interest would rise by ¥3m. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.
Via /v1/companies/4576/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states themSegments, votes and tender offers
Stated in EDINET filings/v1/companies/4576/votingOwnership changes
All companies →- 2026-10-08
Growth Capital Inc. disclosed a 42.96% stake in D.Western Therapeutics Institute, Inc. (4576), crossing the 5% reporting threshold.
- 2026-10-08
Holdings of Growth Capital Inc. in D.Western Therapeutics Institute, Inc. (4576) moved above 10% (new -> 42.96%).
- 2026-10-08
Holdings of Growth Capital Inc. in D.Western Therapeutics Institute, Inc. (4576) moved above 20% (new -> 42.96%).
- 2026-10-08
Holdings of Growth Capital Inc. in D.Western Therapeutics Institute, Inc. (4576) moved above 33.4% (new -> 42.96%).
- 2026-09-15
individual filer raised holdings in D.Western Therapeutics Institute, Inc. (4576) to 9.73% from 9.00%.
- 2026-05-13
individual filer reduced holdings in D.Western Therapeutics Institute, Inc. (4576) to 9.00% from 11.07%.
- 2026-05-13
Holdings of individual filer in D.Western Therapeutics Institute, Inc. (4576) moved below 10% (11.07% -> 9.00%).
- 2026-05-13
individual filer filed a correction to a 5% report on D.Western Therapeutics Institute, Inc. (4576).
- 2026-01-27
individual filer reduced holdings in D.Western Therapeutics Institute, Inc. (4576) to 11.07% from 12.11%.
- 2025-12-04
SBI SECURITIES Co.,Ltd. cut holdings in D.Western Therapeutics Institute, Inc. (4576) to 4.45% from 5.49%, below the 5% threshold.
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| グロース・キャピタル株式会社 | 2026-10-01 – 2026-10-01 | +39,000,000 | +40.37pt | — | — |
| individual filer | 2024-12-30 – 2026-07-17 | -49,700 | −0.11pt | — | — |
| 株式会社SBI証券 | 2025-06-02 – 2025-09-25 | +3,064,400 | +5.48pt | — | — |
| individual filer | 2024-06-03 – 2025-02-04 | +1,540,100 | +3.42pt | ¥92.88 | ¥74–148 |
| individual filer | 2024-12-30 – 2024-12-30 | 0 | 0.00pt | — | — |
| 株式会社ウィズ・パートナーズ | 2022-07-19 – 2024-06-07 | +1,806,315 | +4.06pt | — | — |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4576/trades.
5% filings
Large shareholding reports on 4576| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2026-10-08 | Growth Capital Inc. | 42.96% | — | pure investment |
| 2026-09-15 | individual filer | 9.73% | +0.73pt | — |
| 2026-05-13 | individual filer | 9.00% | −2.07pt | — |
| 2026-05-13 | individual filer | 11.07% | −1.04pt | — |
| 2026-01-27 | individual filer | 11.07% | −1.04pt | — |
| 2025-12-04 | SBI SECURITIES Co., Ltd. | 4.45% | −1.04pt | — |
| 2025-10-21 | SBI SECURITIES Co., Ltd. | 5.49% | −1.79pt | — |
| 2025-10-02 | SBI SECURITIES Co., Ltd. | 7.28% | −4.10pt | — |
| 2025-09-25 | SBI SECURITIES Co., Ltd. | 11.38% | −1.02pt | — |
| 2025-09-11 | SBI SECURITIES Co., Ltd. | 12.40% | −0.87pt | — |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- — issues
- Book value
- —
- Sold in the year
- — — issues
- Bought in the year
- — — issues
- Mutual, both reports
- 0
- Held by listed cos.
- 0
Purposes, all holdings and mutual flags via /v1/companies/4576/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2025-12-31| Shareholder | Shares | Ratio |
|---|---|---|
| individual holder | 5,150,600 | 9.49% |
| 楽天証券株式会社共有口 | 2,311,900 | 4.26% |
| MSIP CLIENT SECURITIES | 1,130,200 | 2.08% |
| 株式会社SBI証券 | 885,918 | 1.63% |
| 株式会社ミートプランニング | 850,000 | 1.56% |
| individual holder | 730,000 | 1.34% |
| SMBC日興証券株式会社 | 592,300 | 1.09% |
| individual holder | 428,800 | 0.79% |
| 日本証券金融株式会社 | 360,500 | 0.66% |
| モルガン・スタンレーMUFG証券株式会社 | 306,113 | 0.56% |
Get this as JSON
GET /v1/companies/4576
GET /v1/companies/4576/financials
GET /v1/companies/4576/details
GET /v1/companies/4576/segments
GET /v1/companies/4576/voting
GET /v1/companies/4576/tender-offers
GET /v1/companies/4576/indicators
GET /v1/companies/4576/earnings-releases
GET /v1/events?ticker=4576
GET /v1/companies/4576/trades
GET /v1/companies/4576/cross-holdings
GET /v1/companies/4576/brief